Strategic use of epidemiology in THE WHO’s vaccine programmes

Dr. John Clements

Department of Vaccines and Immunization, World Health Organization, Geneva

Epidemiological studies are a key element of the disease control strategies of the World Health Organization (WHO). By monitoring disease patterns over time, the WHO’s Department of Vaccines and Immunization is able to plan vaccination policies to achieve the greatest impact. Epidemiological surveys are also important in assessing the success of these policies and any effects that they may have on emerging strains and variants of the causative organisms of various diseases.

Measles is among those infectious diseases that are currently the subject of WHO epidemiological assessments. Although the control of measles is improving globally, significant numbers of susceptible individuals are still to be found within target populations. By identifying and assessing the proportion of these susceptible individuals, the WHO is able to devise additional strategies aimed at promoting wider uptake of the measles vaccine in at-risk populations.

One of the responsibilities of the WHO’s Global Advisory Committee on Vaccine Safety is the assessment of claims received from researchers that specific vaccines may be causally linked to particular adverse events. In order to carry out a thorough evaluation of the situation and either support or refute such claims, a sound understanding of the epidemiological principles is essential. The ability to interpret the complex data that may be generated by the investigations is also required.

Epidemiological assessments are, thus, a vital component of the work of the WHO in both industrialised and developing regions, and are critical to any attempts to improve worldwide control of infectious diseases.